In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy

Boron neutron capture therapy (BNCT) requires pharmaceutical innovations and molecular-based evidence of effectiveness to become a standard cancer therapeutic in the future. Recently, in Japan, 4-borono-L-phenylalanine (BPA) was approved as a boron agent for BNCT against head and neck (H&N) canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Atsushi, Yasui, Seiji, Igawa, Kazuyo, Ueda, Ai, Watanabe, Kaori, Hanafusa, Tadashi, Ichikawa, Yasuaki, Yoshihashi, Sachiko, Tsuchida, Kazuki, Kamiya, Atsunori, Furuya, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598271/
https://www.ncbi.nlm.nih.gov/pubmed/32977522
http://dx.doi.org/10.3390/cells9102149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598271/
https://www.ncbi.nlm.nih.gov/pubmed/32977522
http://dx.doi.org/10.3390/cells9102149

Ejemplares similares